Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide

NCT ID: NCT02803632

Last Updated: 2020-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

98 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-06

Study Completion Date

2018-08-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the \> 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the \> 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit. New approaches have been proposed to these problems that have led us to reorganize our diagnostic practices: 1) more precise characterization of suicidal behaviour by using standardized instruments such as the French version of the Columbia-Suicide Severity Rating Scale developed by Posner (C-SSRS); 2) new clinical entities, such as disruptive mood dysregulation disorder, are now proposed in international classifications (DSM 5 field trial); 3) investigations such as recording of the circadian rhythm of motor activity by actigraphy are being studied as a laboratory complement to psychiatric diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide, Attempted

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

young disruptive mood dysregulation disorder actigraphic profile

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

suicide attempt

questionnaires actigraphic recording

Group Type EXPERIMENTAL

questionnaires

Intervention Type BEHAVIORAL

actigraphic recording

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaires

Intervention Type BEHAVIORAL

actigraphic recording

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children/adolescents admitted after a suicide attempt

Exclusion Criteria

* severe depression
* mental retardation
* pervasive developmental disorder
* active psychotic episode,
* drug and alcohol abuse at the time of admission
* organic sleep-wake disorders (sleep-related respiratory and motor disorders, narcolepsy)
* any contraindication formulated by the clinical team
* patients not covered by French national health insurance, patients deprived of their freedom as stipulated in Article L.1121-6 of the French Public Health Code
Minimum Eligible Age

6 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Marc GUILE, PhD

Role: PRINCIPAL_INVESTIGATOR

CHU Amiens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens

Amiens, , France

Site Status

AP HP

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AOL11-DR -GUILE

Identifier Type: -

Identifier Source: org_study_id